Lifeboat Foundation

The finding that these “hidden” memories can be accessed once more, at least in mice, throws up a world of intriguing possibilities.

Neuroscientist Robbert Havekes and his team at the University of Groningen found that learning while sleep-deprived does not result in memory loss; rather, it is more difficult to recall.

“We previously focused on finding ways to support memory processes during a sleep deprivation episode,” says Havekes.

Continue reading “Researchers successfully bring mice’s memory back with an asthma medicine” »

Depending on how bright C/2022 E3 (ZTF) becomes, it could even be visible to the naked eye.

Scientists recently discovered a green comet that was last visible in the night sky 50,000 years ago — that’s so long ago that the Earth was in the midst of the Ice Age.

Now, a NASA blog post points out the fact that the comet will make its closest approach to the sun on January 12. It will be close enough to Earth that it may be visible to the naked eye.

Continue reading “A green comet will soon be visible from Earth for the first time in 50,000 years” »

Galactic shock is changing Stephan’s Quintet in enigmatic ways, according to ALMA and JWST.

New observations made with the James Webb Space Telescope (JWST) and the Atacama Large Millimeter/submillimeter Array (ALMA) allowed researchers to see the complex interactions within the multi-galaxy collision event known as Stephan’s Quintet.

Stephan’s Quintet is a group of five galaxies-NGC 7,317, NGC 7318a, NGC 7318b, NGC 7,319, and NGC 7,320, located about 270 million light-years from Earth in the constellation Pegasus.

Naeblys/iStock.

Also known as lecanemab, Leqembi is the second drug of its kind – a medication that has been approved for treating Alzheimer’s disease. This type of medication targets the fundamental pathophysiology of the disease and is considered a significant development in the effort to successfully treat Alzheimer’s disease.

Time to reverse your age and restore youth.

Scientists at a San Diego-based biotech company Rejuvenate Bio claim to have increased the age of mice by reprogramming their genes. They believe their gene therapy actually works like a reverse aging technique that one day might be used for rejuvenating humans.

Continue reading “Scientists reprogrammed mice’s genes to live longer, and it worked!” »

Back in 2002, the science fiction film Minority Report once again reignited futuristic imaginations about a world and police state gone too far. At the time, the movie inspired plenty of speculation about the future of our society, how computers would interact with us, and how law enforcement would be carried out proactively based on intent. In the movie, they combined technology with the psychic abilities of the “precogs,” to proactively prevent crimes.

The precogs had the ability to predict when crimes were about to be committed ahead of time, enabling law enforcement to act early.

Twenty years later, in a climate of abundant data, almost limitless processing, and at a point in history where law enforcement is frequently discussed, some of these technologies are beginning to look more feasible than ever.

Continue reading “AI Tools: From Minority Report To Mission Possible” »

You have probably heard of ChatGPT and DALLE-E, a new class of AI-powered software tools that can create new images or write text. The algorithm brings to life any idea you may have by putting together fragments of what it has previously seen — such as images annotated with meta-descriptions of what they represent — to generate original content from user-defined input. But now generative AI technology is revolutionizing drug discovery. Absci Corporation (Nasdaq: ABSI) is using machine learning to transform the field of antibody therapeutics: Absci has put out a press release today announcing the ability to create new antibodies with the use of generative AI.

GenerativeAI: You’ve seen it with images like DALL-E, you’ve seen it with text like ChatGPT. Now you can see it with protein design as well.

Apple today shared an update on its subscription businesses and global App Store, noting that the tech company has now paid out a record $320 billion to app developers since 2008 — a number that reflects the revenue apps have generated, minus Apple’s commission. In addition, the tech giant said it now has more than 900 million paid subscriptions across Apple services, with subscriptions on the App Store driving a “significant” part of that figure.

The company’s App Store in 2022 faced one of its tougher years since its founding, with lawsuits and antitrust actions aimed at limiting its market power.

Google has warned that growth in the use of Android in India may stall due to an antitrust order issued by the Indian antitrust watchdog last year over the U.S. company’s domination in the country.

The order, which was issued by the Competition Commission of India (CCI) in September, found that Google had abused its dominant position in the market for mobile operating systems by imposing restrictive contracts on mobile manufacturers.

The CCI ordered Google to change its contracts with manufacturers, allowing them more freedom to install rival apps and services on Android devices. According to a Reuters report, Google filed a challenge with India’s Supreme Court and said that the order would require some modifications of its existing contracts and new license agreements. It would alter the company’s existing arrangements with over 1,100 device manufacturers and thousands of app developers.